MUMBAI, India, Feb. 27 -- Intellectual Property India has published a patent application (202641017903 A) filed by Sr University, Warangal, Telangana, on Feb. 17, for 'hybrid multimodal clinical intelligence system for leukemia risk stratification using hematological, genomic, and narrative data.'
Inventor(s) include Sridhar Babu Nalla; and Dr. Vivek Kumar Dhimole.
The application for the patent was published on Feb. 27, under issue no. 09/2026.
According to the abstract released by the Intellectual Property India: "The current invention offers a Hybrid Multimodal Clinical Intelligence System that allows specifying a risk of Leukemia in the form of precise risk stratification using hematological, genomic, and narrative data. The system employs a domain-adapted transformer (such as BioClinicalBERT) to decipher unstructured clinical notes and has a special negation-scope module that eliminates the occurrence of polarity errors in diagnostic interpretation. The quantitative blood parameters and genomic mutations are coded by special neural streams and combined by a learnable Gated Fusion Layer, which flexibly balances each of the modalities by its clinical value and internal consistency. The framework uses hierarchical context encoder to predict the disease progression between physician notes and uses negation-sensitive calibration loss to create diagnostic accuracy. The invention gives oncologists a risk score (Low, Intermediate, High, Very High), which is interpretable on a Risk Attribution Map, of the most important genomic markers and narrative phrases that are driving the prognosis. The system provides a transparent and scalable solution to personalized oncology management by closing the gap between molecular data (high-dimensional) and unstructured and semantically rich clinical discourse, which can be verified by a clinician."
Disclaimer: Curated by HT Syndication.
